Qiaoyang Ning
Harbin Medical University(CN)Third Affiliated Hospital of Harbin Medical University(CN)
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → A Histone Acetyltransferase p300 Inhibitor C646 Induces Cell Cycle Arrest and Apoptosis Selectively in AML1-ETO-Positive AML Cells(2013)100 cited
- → AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation(2015)96 cited
- → Increased PRAME-Specific CTL Killing of Acute Myeloid Leukemia Cells by Either a Novel Histone Deacetylase Inhibitor Chidamide Alone or Combined Treatment with Decitabine(2013)77 cited
- → High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin’s lymphoma in China(2017)38 cited
- → A novel epigenetic AML1‐ETO/THAP10/miR‐383 mini‐circuitry contributes to t(8;21) leukaemogenesis(2017)37 cited
- → SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia(2016)32 cited
- → [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].(2019)5 cited
- → SPOP Is a Key Trigger of Pathological Cardiac Hypertrophy and Heart Failure(2025)1 cited
- → [The prognostic impact of diabetic mellitus and hyperglycemia during DLBCL treatment on patients with diffuse large B-cell lymphoma].(2021)1 cited
- → Ibrutinib inhibits diffuse large B-cell lymphoma cell survival(2017)